Expectation of Driving Performance in Young Adults With ADHD Assessed by Driving Simulator and Seat Pressure Mapping

Attention Deficit Hyperactivity Disorder Clinical Trial

Official title:

Expectation of Driving Performance in Young Adults With ADHD Assessed by Driving Simulator and Seat Pressure Mapping

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01179386
• Other study ID #: hermanadhd
• Status: Not yet recruiting
• Phase: N/A
• First received: August 9, 2010
• Last updated: August 27, 2011
• Start date: November 2011
• Est. completion date: December 2011

Study information

• Verified date: August 2011
• Source: Meir Medical Center
• Contact: Dr Cohen Herman, MD
• Phone: 972-3-9398200
• Email: hermanc[@]post.tau.ac.il
• Is FDA regulated: No
• Health authority: Israel: Ethics Commission
• Study type: Observational

Clinical Trial Summary

Adolescents suffering of ADHD may have impaired driving performance. The investigators would like to check the differences in driving performance in young adults(aged: 15-18 years) with ADHD by driving simulator and seat pressure mapping with and without methylphenidate medication.

Description:

Adolescents with ADHD who are treated with one of the methylphenidate medication that is in use in Israel(Ritalin,Ritalin SR,Concerta,Ritalin LA)will be tested by driving simulator and seat pressure mapping by 2 stages: 1.when they are taking the medication that they are taking every day to control ADHD and: 2. without medication ( after 4 day washout period).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: December 2011
• Est. primary completion date: December 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 15 Years to 18 Years

Eligibility

Inclusion Criteria:

• age 15-18 years Suffering from ADHD treated by methylphenidate before receiving driving license

Exclusion Criteria:

• any other neurological or psychiatric problem under treatment or investment adolescents who have driving license

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Attention Deficit Disorder with Hyperactivity
• Attention Deficit Hyperactivity Disorder

Locations

Country	Name	City	State
Israel	Cohen Herman Avner	Petah-Tikva

Sponsors (1)

Lead Sponsor	Collaborator
Meir Medical Center

Country where clinical trial is conducted

Israel, 

References & Publications (1)

Cox DJ, Humphrey JW, Merkel RL, Penberthy JK, Kovatchev B. Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder. J Am Board Fam Pract. 2004 Jul-Aug;17(4):235-9. — View Citation